Purchase Order 75N91023P00874
Award Date 9/22/23
Potential Completion Date 12/26/23
Potential Value $25K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Denville, NJ 07834, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Cancer Institute awarded a purchase order to Diagenode, LLC for scientific equipment with a ceiling value of $22,682.10, effective June 19, 2020. The order, which is firm fixed-price with no small business set-aside, calls for equipment to be delivered to Denville, New Jersey, where the awardee is headquartered. Ultimate completion was scheduled for June 18, 2021.</p>
- <p>The National Cancer Institute awarded a purchase order to Diagenode, LLC for $24,284.30 in scientific laboratory equipment, effective March 12, 2021, with completion by April 11, 2021. Performance occurs in Denville, New Jersey. The order is firm fixed price with no small business set-aside.</p>
- The National Cancer Institute (NCI) awarded a $23,969.15 firm-fixed-price purchase order to Diagenode, LLC, a global life sciences company specializing in epigenetics research. The contract is for the delivery of a Bioruptor PLUS sonication device, which is used for DNA shearing in chromatin immunoprecipitation (ChIP) workflows. Diagenode has secured numerous federal contracts from agencies such as the National Institutes of Health (NIH), Environmental Protection Agency (EPA), and U.S....
- The U.S. National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), awarded a $23,945.00 firm fixed-price purchase order to Diagenode, LLC, a small business specializing in epigenetics research and laboratory services. The contract is for the delivery of lab equipment, including DNA shearing devices, methylation arrays, and other specialized instruments to support genomic research initiatives. Diagenode has previously secured multiple...
- <p>The National Human Genome Research Institute awarded a purchase order to Diagenode, LLC for laboratory equipment and supplies valued at $24,727.60 on February 27, 2019. Performance is located in Denville, New Jersey. The order is firm fixed price with an ultimate completion date of March 26, 2019. No small business set-aside was used.</p>
- The National Institute on Aging issued a purchase order to Diagenode, LLC on January 27, 2020, with a ceiling value of $23,308.50 for firm fixed-price commercial items. Performance is scheduled to conclude by April 6, 2020, and will be executed in Denville, New Jersey, where the awardee is headquartered. The order procures specialized laboratory instrumentation and epigenetics research services, including DNA analysis tools and associated genomic methodologies aligned with the institute's...
- This federal contract award is for the maintenance, repair, and rebuilding of instruments and laboratory equipment. The contract was awarded to Diagenode, LLC, a global life sciences company specializing in epigenetics research and laboratory services. The contract has a ceiling value of $9,800.00 and was awarded on February 15, 2012 by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH), a civilian agency. The contract is a...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $20,570 purchase order to Oxford Nanopore Technologies Inc. for laboratory supplies. The firm fixed price contract runs from August 17, 2023 to January 5, 2024 and will be performed in New York, New York. As the National Cancer Institute supports research to advance cancer prevention, diagnosis, and treatment, this contract will likely provide supplies to enable NCI-funded laboratory...
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded Roche Diagnostics Corporation a $20,463.87 firm fixed price delivery order for reagents and consumables. The contract has no set-aside designation and runs through January 13, 2023. As the largest biomedical research agency in the world, the National Cancer Institute works with both public and private partners to better understand, diagnose, and treat cancer. This delivery order...
- This is a firm-fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Eye Institute to Diagenode, LLC, a for-profit limited liability company, for epigenetics research and biological sample preparations. The $37,441.44 contract has a completion date of May 21, 2025 and does not utilize a set-aside designation. Diagenode is a global leader in epigenetics research, offering specialized instruments, reagents, and analytical...